B2W-23407-50499
3 vaccinations
7 coded responses
25 check-ins
7 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 537 / WI
- Registered
- 2020-12-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-27
Registered in v-safe
-
2020-12-27
Dose 1 — Pfizer-BioNTech
- 2020-12-27
-
2020-12-28
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Good · Site: Pain · Headache, Fatigue or tirednessFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-29
- 2020-12-30
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-10
-
2021-01-17
Dose 2 — Pfizer-BioNTech
- 2021-01-17
-
2021-01-18
Survey response — days 1–6 daily, dose 2MedDRA: Disturbance in attention, Dizziness, Neck pain — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Light headedness, decreased concentration, neck pain- soft tissue with full AROMMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-31
-
2021-02-07
Survey response — day 21, dose 2MedDRA: Headache, Oropharyngeal pain, SARS-CoV-2 antibody test negative — Feeling: Good · Be unable to workFree text: I developed a sore throat and mild headache on Thursday morning 2/4. Stayed home from work. Isolated. Tested negative for COVID. Back to clinic the next day.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-14
-
2021-02-21
Survey response — day 35, dose 2MedDRA: Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: Good · Be unable to workFree text: Intermittent sore throat. Developed in the night on two occasions. No fever, marked congestion or other constitutional symptoms. Both resolved the day after. Took off one day of work to get tested. Result for COVID negative. Other was on weekend.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-28
- 2021-04-20
- 2021-07-18
-
2021-11-19
Dose 3 — Pfizer-BioNTech
- 2022-01-17
-
2022-02-18
Survey response — 3 months, dose 3MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: GoodFree text: Sore throat, rhinorrheaMedDRA releases: 2024-11 · check-in free text available
-
2022-05-20
Survey response — 6 months, dose 3MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throat x 2 days in mid April.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-19
Survey response — 12 months, dose 3MedDRA: COVID-19, Cough, Fatigue, Oropharyngeal pain — Feeling: Good · Be unable to work or attend schoolFree text: COVID with fatigue, sore throat, coughMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-27 | Pfizer-BioNTech | |
| 2 | 2021-01-17 | Pfizer-BioNTech | |
| 3 | 2021-11-19 | Pfizer-BioNTech | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): No
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Light headedness, decreased concentration, neck pain- soft tissue with full AROM
Release 3 — day 21, dose 2
Symptoms: I developed a sore throat and mild headache on Thursday morning 2/4. Stayed home from work. Isolated. Tested negative for COVID. Back to clinic the next day.
Release 4 — day 35, dose 2
Symptoms: Intermittent sore throat. Developed in the night on two occasions. No fever, marked congestion or other constitutional symptoms. Both resolved the day after. Took off one day of work to get tested. Result for COVID negative. Other was on weekend.
Release 11 — 3 months, dose 3
Symptoms: Sore throat, rhinorrhea
Release 11 — 6 months, dose 3
Symptoms: Sore throat x 2 days in mid April.
Release 12 — 12 months, dose 3
Symptoms: COVID with fatigue, sore throat, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 antibody test negative | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SRO | Disturbance in attention | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Neck pain | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release